Story perspectives

UK Approves First Homegrown mRNA Vaccine: Moderna's Spikevax

2/11/2026

Summary

Story summary

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Moderna’s Covid-19 Spikevax as the first domestically manufactured mRNA vaccine for NHS.
Production will be at Moderna Innovation and Technology Centre in Harwell, Oxfordshire.
Capacity can reach 100 million doses annually, rising to 250 million in a pandemic.
Moderna has invested over £1 billion in UK R&D under a 10-year government partnership to create around 150 skilled jobs.

1 of 1

Story summary

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Moderna’s Covid-19 Spikevax as the first domestically manufactured mRNA vaccine for NHS.
Production will be at Moderna Innovation and Technology Centre in Harwell, Oxfordshire.
Capacity can reach 100 million doses annually, rising to 250 million in a pandemic.
Moderna has invested over £1 billion in UK R&D under a 10-year government partnership to create around 150 skilled jobs.